anonymous
Guest
anonymous
Guest
My apologies to those suffering from psoriasis. I am positive that psoriasis is more than a cosmetic condition to those that suffer from the disease. I don't believe in this company's leadership and their business model.
This is a good walk back. Psoriasis is well more than a cosmetic condition, with the internal inflammation causing it affecting much more than the skin. That said, your initial supposition is true. While Duobbri might be a decent product, the fact that it’s over $800 is a signal that the current pharma pricing model is broken beyond repair. In what universe are two generics mixed together worth $800? Why, in the OD universe, of course! How any payer reimburses for that nonsense is baffling.